Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Robert-Paganin

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biomed Research International|February 19, 2015
Regulation of DEAH/RHA helicases by G-patch proteinsJulien Robert-Paganin, Stéphane Réty, Nicolas Leulliot
Nature Communications|October 3, 2018
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibitionJulien Robert-Paganin, Daniel Auguin, Anne Houdusse
Advances in Experimental Medicine and Biology|May 27, 2020
Myosin StructuresH Lee Sweeney, Anne Houdusse, Julien Robert-Paganin
Plos One|January 4, 2013
Crystal structure of an EAL domain in complex with reaction product 5'-pGpGJulien Robert-Paganin, Sylvie Nonin-Lecomte, Stéphane Réty
Chemical Reviews|November 6, 2019
Force Generation by Myosin Motors: A Structural PerspectiveJulien Robert-Paganin, Olena Pylypenko, Carlos Kikuti, et al.
Biomolecules|April 23, 2022
A Perspective for Ménière's Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2Robin Mom, Julien Robert-Paganin, Thierry Mom, et al.
The EMBO Journal|August 27, 2024
Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathyJames A Spudich, Neha Nandwani, Julien Robert-Paganin, et al.
Nature Communications|August 5, 2017
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbilVicente J Planelles-Herrero, James J Hartman, Julien Robert-Paganin, et al.
FEBS Letters|September 30, 2020
Voltage-gating of aquaporins, a putative conserved safety mechanism during ionic stressesRobin Mom, Beatriz Muries, Pierrick Benoit, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contractionDaniel Auguin, Julien Robert-Paganin, Stéphane Réty, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biomed Research International|February 19, 2015
Regulation of DEAH/RHA helicases by G-patch proteinsJulien Robert-Paganin, Stéphane Réty, Nicolas Leulliot
Nature Communications|October 3, 2018
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibitionJulien Robert-Paganin, Daniel Auguin, Anne Houdusse
Advances in Experimental Medicine and Biology|May 27, 2020
Myosin StructuresH Lee Sweeney, Anne Houdusse, Julien Robert-Paganin
Plos One|January 4, 2013
Crystal structure of an EAL domain in complex with reaction product 5'-pGpGJulien Robert-Paganin, Sylvie Nonin-Lecomte, Stéphane Réty
Chemical Reviews|November 6, 2019
Force Generation by Myosin Motors: A Structural PerspectiveJulien Robert-Paganin, Olena Pylypenko, Carlos Kikuti, et al.
Biomolecules|April 23, 2022
A Perspective for Ménière's Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2Robin Mom, Julien Robert-Paganin, Thierry Mom, et al.
The EMBO Journal|August 27, 2024
Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathyJames A Spudich, Neha Nandwani, Julien Robert-Paganin, et al.
Nature Communications|August 5, 2017
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbilVicente J Planelles-Herrero, James J Hartman, Julien Robert-Paganin, et al.
FEBS Letters|September 30, 2020
Voltage-gating of aquaporins, a putative conserved safety mechanism during ionic stressesRobin Mom, Beatriz Muries, Pierrick Benoit, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contractionDaniel Auguin, Julien Robert-Paganin, Stéphane Réty, et al.
Pageof 3